Press Release & Update
- HOME
- Press Release & Update
-
2023/09/27Press Release
VLPT Japan, Biken Foundation, Denka sign agreement to develop self-amplifying “replicon” RNA influenza vaccine
-
2023/09/14
VLPT Japan, Biken Foundation sign MoU on potential business alliance eying 2023 conclusion of “replicon” RNA COVID-19 vaccine production, sales license agreement
-
2023/06/19Notice
Announcement of BIKEN Group’s new board members
-
2023/03/27Press Release
Approval of “GOBIK Aqueous Suspension Syringes”, Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine
-
2022/04/11Press Release
Marketing Authorization Application of Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine (BK1310/MT-2355)
-
2019/11/11Press Release
Regarding the Incident of Vaccine Culture Fluid Leakage at Seto Office
-
2017/05/09Press Release
Establishment of Vaccine Manufacturing Joint Venture: BIKEN Co.,Ltd.
-
2016/11/08Press Release
Basic Agreement on the Establishment of a Joint Venture
-
2016/09/06Press Release
BIKEN begins development of Zika virus vaccine, upon concluding agreement on virus distribution with Chiba Prefectural Institute of Health
-
2016/06/30Notice
BIKEN additionally supports recovery efforts from The 2016 Kumamoto Earthquake
-
2016/04/26Press Release
BIKEN supports recovery efforts from The 2016 Kumamoto Earthquake
-
2016/04/05Update
The page of Research & Development is released.
-
2016/04/01Press Release
Biken joins the Japan Pharmaceutical Manufacturers Association
-
2016/04/01Press Release
Announcement of Organizational Changes and Personnel Changes
-
2015/12/21Update
We have posted our new foundation brochure.
-
2015/04/06Press Release
BIKEN Enters into a License Agreement with Osaka University for the Development of a New Pneumococcal Vaccine